| Sandra S Edwards, PT | |
|
110 Oxmoor Ct, Birmingham, AL 35209-6341 | |
| (615) 778-4066 | |
| Not Available |
| Full Name | Sandra S Edwards |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 32 Years |
| Location | 110 Oxmoor Ct, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396869616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | PT1850 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Therapy South-bessemer, Llc | 8729175781 | 6 |
News Archive
The Female Health Company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share. The dividend is payable February 7, 2011 to stockholders of record as of January 31, 2011.
Parents with allergies are more likely to pass them on to their same gender children than to children of the opposite gender, say researchers.
Patients with congenital heart disease are up to 85 times more likely to suffer from atrial fibrillation as adults. The researchers behind a study, published in the journal Circulation, are now advocating more frequent screenings of the most vulnerable groups.
In an article recently recommended by Bradley Kropp of Faculty of 1000 Medicine, researchers find chewing gum is a simple solution to the recovery of bowel function after gastrointestinal surgery – a problem that has troubled patients and physicians for decades.
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.
› Verified 5 days ago
| Entity Name | Therapy South-bessemer, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801081468 PECOS PAC ID: 8729175781 Enrollment ID: O20071107000674 |
News Archive
The Female Health Company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share. The dividend is payable February 7, 2011 to stockholders of record as of January 31, 2011.
Parents with allergies are more likely to pass them on to their same gender children than to children of the opposite gender, say researchers.
Patients with congenital heart disease are up to 85 times more likely to suffer from atrial fibrillation as adults. The researchers behind a study, published in the journal Circulation, are now advocating more frequent screenings of the most vulnerable groups.
In an article recently recommended by Bradley Kropp of Faculty of 1000 Medicine, researchers find chewing gum is a simple solution to the recovery of bowel function after gastrointestinal surgery – a problem that has troubled patients and physicians for decades.
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sandra S Edwards, PT 720 Cool Springs Blvd, Franklin, TN 37067-2626 Ph: (615) 778-4066 | Sandra S Edwards, PT 110 Oxmoor Ct, Birmingham, AL 35209-6341 Ph: (615) 778-4066 |
News Archive
The Female Health Company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share. The dividend is payable February 7, 2011 to stockholders of record as of January 31, 2011.
Parents with allergies are more likely to pass them on to their same gender children than to children of the opposite gender, say researchers.
Patients with congenital heart disease are up to 85 times more likely to suffer from atrial fibrillation as adults. The researchers behind a study, published in the journal Circulation, are now advocating more frequent screenings of the most vulnerable groups.
In an article recently recommended by Bradley Kropp of Faculty of 1000 Medicine, researchers find chewing gum is a simple solution to the recovery of bowel function after gastrointestinal surgery – a problem that has troubled patients and physicians for decades.
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.
› Verified 5 days ago
Kevin C. Staudinger, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 833 Princeton Ave Sw, Pob Ii; Suite 150, Birmingham, AL 35211 Phone: 205-781-2699 Fax: 205-781-2690 | |
Catarina I Kiefe, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Frank P Notgrass, PHYSICIAN-H Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 Oxmoor Ct, Birmingham, AL 35209 Phone: 615-778-4066 | |
Albert Oberman, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Matthew N Parker, M.D. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 50 Manning Pl, Birmingham, AL 35242 Phone: 205-995-4690 Fax: 205-995-4695 | |
Andre' Mcshan, Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Dr. Michael A Mueller, MD, MPH Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1201 11th Ave. So., Suite 100, The Workplace, Birmingham, AL 35205 Phone: 205-933-5300 Fax: 205-930-1928 |